Women-Focused Education in Cardiac Rehab

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot randomized trial tests a women-tailored education program called Cardiac College for Women, added to usual cardiac rehabilitation, versus usual rehab alone. Participants are adult women enrolled in participating cardiac rehabilitation programs and randomized to receive the enhanced education or standard care. The study aims to assess feasibility of delivering the program within routine rehab, and whether the intervention improves heart health knowledge, quality of life, and health behaviors. The program builds on patient education principles and behavior theories and is delivered in English or French where available. Outcomes will inform whether this approach can be scaled across diverse rehabilitation settings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Identify as a woman
* Aged 18 years or older
* Enrolled in a participating cardiac rehabilitation program
* Diagnosis consistent with cardiac rehabilitation eligibility (e.g., coronary artery disease, myocardial infarction, revascularization procedures, spontaneous coronary artery dissection, myocardial infarction with non-obstructive coronary arteries, Takotsubo cardiomyopathy, or heart failure)
* Able to provide informed consent
* Able to participate in educational sessions in English or French (site-dependent)

Exclusion Criteria:

* Medical, cognitive, or psychiatric conditions that would prevent participation in educational sessions or completion of study questionnaires
* Inability to access or use online educational sessions or digital materials required for the intervention

Where it's running

• UHN Cardiovascular Prevention Program
  Toronto, Ontario, Canada Recruiting
• Cardiovascular Rehabilitation Program, Royal Victoria Regional Health Centre
  Barrie, Ontario, Canada Not yet recruiting
• Programme PREV
  Lévis, Quebec, Canada Not yet recruiting

Study contacts

• Principal investigator: Gabriela LM Ghisi, PhD — University Health Network, Toronto
• Study coordinator: Gabriela LM Ghisi, PhD
• Email: gabriela.meloghisi@uhn.ca
• Phone: 4165973422

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• TRIFORMIS RESILIA heart valve real-world results in tricuspid disease

  A real-world, observational study to see how the Edwards TRIFORMIS RESILIA tricuspid heart valve performs in adults needing tricuspid valve replacement.

  Recruiting Edwards Lifesciences · Carmel, Indiana · NCT07684313

• Coronary CT angiography–guided calcium modification during PCI for calcified coronary artery disease

  This study will see if using CT angiography to plan calcium treatment before stenting helps people with flow-limiting, calcified coronary artery disease have better stent results and faster procedures compared with the usual ultrasound-guided PCI while keeping similar safety.

  Recruiting at 10 sites Fundación EPIC · Boston, Massachusetts and 14 other locations · NCT07286578

• Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions

  This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.

  Recruiting at 3 sites Teleflex · Washington D.C., District of Columbia and 2 other locations · NCT07258290

• Predicting depression in patients after heart surgery

  This study is trying to see if a new tool can help predict which patients might develop depression after heart surgery, so they can get help sooner.

  Recruiting University of Zurich · Zurich and 1 other locations · NCT06706323

• Comparing heart imaging techniques for coronary artery disease

  This study is testing if a new heart imaging method can better identify problems in patients suspected of having coronary artery disease compared to a traditional imaging technique.

  Recruiting Semmelweis University · Budapest, Budapest · NCT06670768

• Natural history of PKP2-related arrhythmogenic cardiomyopathy

  This project will collect past and ongoing health information to see how PKP2-related arrhythmogenic cardiomyopathy progresses in people managed with standard care.

  Recruiting at 2 sites Rocket Pharmaceuticals Inc. · Boston, Massachusetts and 2 other locations · NCT06644742

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.